QUALITY OF LIFE OF HEREDITARY ANGIOEDEMA (HAE) PATIENTS WITH DEPRESSION OR ANXIETY RECEIVING LANADELUMAB

被引：0
|
作者：
Craig, T.
Soteres, D.
Anderson, J.
Paes, K.
Hao, J.
Hashemi, L.
Watt, M.
Juethner, S.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2020年 / 125卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P163
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetic/Pharmacodynamic Analysis of Lanadelumab in Patients with Hereditary Angioedema (HAE)
    Chang, Colin
    Offman, Elliot
    Marier, J. F.
    Martin, Patrick
    Wang, Yi
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S55 - S55
  • [2] Health-Related Quality of Life (HRQoL) in Pediatric Patients with Hereditary Angioedema (HAE) Receiving Lanadelumab: Exploratory Results From the SPRING Study
    Watt, Maureen
    Maurer, Marcus
    Lumry, William
    Li, H. Henry
    Aygoeren-Puersuen, Emel
    Busse, Paula
    Jacobs, Joshua
    Nurse, Christina
    Yu, Ming
    Romanus, Dorothy
    Devercelli, Giovanna
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB139 - AB139
  • [3] Lanadelumab improves health-related quality of life in patients with hereditary Angioedema (HAE): findings from the HELP study
    Longhurst, Hilary
    Lumry, William
    Weller, Karsten
    Magerl, Markus
    Lu, Peng
    Jain, Gagan
    Lewis, Hannah
    Maurer, Marcus
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (11): : 1524 - 1525
  • [4] SUBCUTANEOUS SELF-ADMINISTRATION OF LANADELUMAB FOR PROPHYLACTIC TREATMENT IN PATIENTS WITH HEREDITARY ANGIOEDEMA (HAE)
    Lumry, W.
    Busse, P.
    Lu, P.
    Jain, G.
    Nurse, C.
    Maurer, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S57 - S57
  • [5] Efficacy and safety of lanadelumab for prophylactic treatment in adolescents with hereditary angioedema (HAE)
    Busse, Paula J.
    Tachdjian, Raffi
    Martinez-Saguer, Inmaculada
    Lu, Peng
    Nurse, Christina
    Aygoren-Pursun, Emel
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB44 - AB44
  • [6] Depression and anxiety in patients with hereditary angioedema
    Fouche, Andrew S.
    Saunders, Erika F. H.
    Craig, Timothy
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 112 (04) : 371 - 375
  • [7] RELEVANCE OF PLASMA KALLIKREIN (PKAL) LEVELS FOR LANADELUMAB PHARMACOKINETICS (PK) IN PATIENTS WITH HEREDITARY ANGIOEDEMA (HAE).
    Ahmed, M.
    Wang, Y.
    Zhu, A.
    Sexton, D.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S5 - S6
  • [8] Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study
    Lumry, William R.
    Weller, Karsten
    Magerl, Markus
    Banerji, Aleena
    Longhurst, Hilary J.
    Riedl, Marc A.
    Lewis, Hannah B.
    Lu, Peng
    Devercelli, Giovanna
    Jain, Gagan
    Maurer, Marcus
    [J]. ALLERGY, 2021, 76 (04) : 1188 - 1198
  • [9] Long-term Efficacy and Safety of Lanadelumab for Prophylactic Treatment in Adolescent Patients with Hereditary Angioedema (HAE)
    Busse, Paula
    Tachdjian, Raffi
    Longhurst, Hilary
    Lu, Peng
    Nurse, Christina
    Anderson, John
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB103 - AB103
  • [10] Relationship Between Angioedema Attacks and Health-Related Quality Of Life Outcomes In Patients With Hereditary Angioedema (HAE)
    Dayno, Jeff
    Miller, Dave P.
    Hautamaki, Emily
    Newcomer, Scott
    Fitts, David
    Lumry, William R.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB33 - AB33
12345